Stock CTXR CITIUS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Citius Pharmaceuticals, Inc.

Equities

CTXR

US17322U2078

Market Closed - Nasdaq
Other stock markets
 20:59:47 04/06/2024 BST 		5-day change 1st Jan Change
0.6369 USD -4.28% Intraday chart for Citius Pharmaceuticals, Inc. +0.79% -15.81%
05-21 Citius Pharmaceuticals, Inc. Achieves Primary and Secondary Endpoints in Phase 3 Trial of Mino-Lok Antibiotic Lock Solution CI
05-14 Citius Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CITIUS PHARMACEUTICALS, INC. Stock Citius Pharmaceuticals, Inc.
 120M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 56.65B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 39.44B
LONZA GROUP AG Stock Lonza Group AG
 39.03B
CELLTRION, INC. Stock Celltrion, Inc.
 26.86B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.75B
  1. Stock Market
  2. Equities
  3. CTXR Stock
  4. Charts Citius Pharmaceuticals, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW